Spironolactone Use in Patients with Reduced Ejection Fraction Heart Failure (HFrEF) or Preserved Ejection Fraction Heart Failure (HFpEF)

    Basic Details
    Date Posted
    Tuesday, August 25, 2020
    Status
    Complete
    Medical Product
    spironolactone
    Description

    In this report we examined the number of individuals with reduced ejection fraction heart failure (HFrEF) or preserved ejection fraction heart failure (HFpEF) in the Sentinel Distributed Database (SDD) and described the utilization of spironolactone among these individuals.

    The study period included data from July 1, 2010 to September 30, 2018. We distributed the request to 16 Data Partners on February 13, 2020.

    Additional Details
    FDA Center
    CDER
    Time Period
    July 1, 2010 - September 30, 2018
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    All individuals
    Data Sources
    Sentinel Distributed Database (SDD)